This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPEC0409P_M.jpg
Bristol-Myers Squibb announced earnings per share of $1.72 on revenue of $10.78B. Analysts polled by Investing.com anticipated EPS of $1.51 on revenue of $9.45B. That with comparison to EPS of $1.1 on revenue of $5.92B in the same period a year before. Bristol-Myers Squibb had reported EPS of $1.22 on revenue of $7.95B in the previous quarter. Analysts are expecting EPS of $1.59 and revenue of $10.4B in the upcoming quarter.
Bristol-Myers Squibb shares are down 37% from the beginning of the year , still down 10.55% from its 52 week high of $68.34 set on January 22. They are under-performing the S&P 500 which is down 12.21% year to date.
Bristol-Myers Squibb’s report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Novartis ADR had beat expectations on April 28 with first quarter EPS of $1.56 on revenue of $12.28B, compared to forecast for EPS of $1.39 on revenue of $12B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
